Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 619-622

  MacLennan, S J ^a   Reynen, P H ^a   Kwan, J ^a   Bonhaus, D W ^a  

^a Center for Biological Research   (United States)

Author keywords

35S GTP S; Cannabinoids; CB1 receptor; CB2 receptor; Human recombinant receptors; Inverse agonism; SR141716A

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABINOL; RIMONABANT;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANNABINOIDS; CHO CELLS; CRICETINAE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECOMBINANT PROTEINS;

EID: 0031861372     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701915     Document Type: Article

References (12)

1. BOUABOULA, M., PERRACHON, S., MILLIGAN, L., CANAT, X., RINALDI-CARMONA, M., PORTIER, M., BARTH, F., CALANDRA, B., PECCEU, F., LUPKER, J., MAFFRAND, J-P., LE FUR, G. & CASELLAS, P. (1997). A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. J. Biol. Chem., 272, 22330-22339.
2. DEUTSCH, D.G., LIN, S., HILL, W.A.G., MORSE, K.L., SALEHANI, D., ARREAZA, G., OMEIR, R.L. & MAKRIYANNIS, A. (1997). Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem. Biophys. Res. Commun., 231, 217-221.
3. 2 receptors. Mol. Pharmacol., 48, 443-450.
4. FELDER, C.C., NIELSEN, A., BRILEY, E.M., PALKOVITS, M., PRILLER, J., AXELROD, J., NGUYEN, D.N., RICHARDSON, J.M., RIGGIN, R.M., KOPPEL, G.A., PAUL, S.M. & BECKER, G.W. (1996). Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett., 393, 231-235.
5. KAMINSKI, N.E., ABOOD, M.E., KESSLER, F.K., MARTIN, B.R. & SCHATZ, A.R. (1992). Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol., 42, 736-742.
6. 1 receptor. Eur. J. Pharmacol., 334, R1-R2.
7. PERTWEE, R.G. (1996). Cannabinoid receptor ligands: clinical and neuropharmacological considerations relevant to future drug discovery and development. Exp. Opin. Invest. Drugs, 5, 1245-1253.
8. 1 receptors in mouse urinary bladder. Br. J. Pharmacol. 118, 2053-2058.
9. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
10. RICHARDSON, J.D., AANONSEN, L. & HARGREAVES, K.M. (1997). SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol., 319, R3-R4.
11. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
12. STELLA, N., SCHWEITZER, P. & PIOMELLI, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.